Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0001193125-26-019697

Options or other derivatives

  • Chief Medical Officer acquired 420,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Louis Chrystal Chief Medical Officer 2026-01-20 Grant or award · Stock Option (Right to Buy) +420,000 420,000 D
Loading xslF345X05/ownership.xml…